ICL Israel Chemicals Ltd (ICL)
Official siteBASIC MATERIALS • AGRICULTURAL INPUTS • NYSE
Market Cap: $6.03B
Last updated: Nov 17, 2026 at 4:15 PM ET
ICL Israel Chemicals Ltd (ICL) Statistics
ICL Israel Chemicals (ICL) has a market cap of $6.03B and an enterprise value of $8.80B. Its dividend yield is 5.35%.
Total Valuation
Enterprise value is 45.94% above the market cap, as debt exceeds cash.
| Market Cap | $6.03B |
|---|---|
| Enterprise Value | $8.80B |
| Latest price (Nov 17, 2026) | $4.33 |
Key Dates
The last ex-dividend date was Sep 2, 2026.
| Last Earnings Date | Nov 10, 2026 |
|---|---|
| Last Ex-Dividend Date | Sep 2, 2026 |
| Last Payment Date | Sep 16, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.7x and 0.9x. Its year-end P/S ranged from 0.9x to 1.8x from 2016 to 2025.
| Forward P/E | 11.3x |
|---|---|
| P/S Ratio | 0.7x |
| Forward P/S | 0.8x |
| P/B Ratio | 0.9x |
| P/TBV Ratio | 1.1x |
| P/FCF Ratio | 24.4x |
| P/OCF Ratio | 5.9x |
Enterprise Valuation
Counting debt and cash, the company is valued at 5.4x EBITDA and 36.5x free cash flow.
| EV / Earnings | 28.4x |
|---|---|
| EV / Sales | 1.1x |
| EV / EBITDA | 5.4x |
| EV / EBIT | 9.8x |
| EV / FCF | 36.5x |
Price Statistics
The stock is down 18.51% over 52 weeks and trades 12.88% below its 50-day average.
| Beta (1Y) | 0.51 |
|---|---|
| 52-Week Change | -18.51% |
| 1-Month Change | -11.17% |
| 3-Month Change | -20.40% |
| 6-Month Change | -32.07% |
| 5-Year Change | -47.17% |
| 10-Year Change | +29.75% |
| Total Return (1Y) | -14.64% |
| Total Return (3Y CAGR) | -2.24% |
| Total Return (5Y CAGR) | -9.81% |
| Return vs SPY (1Y) | -29.01% |
| Max Drawdown (1Y) | -35.26% |
| Max Drawdown (3Y) | -39.13% |
| Sharpe Ratio (1Y) | -0.55 |
| Correlation with SPY (1Y) | 0.20 |
| 50-Day Average | $4.97 |
| 200-Day Average | $5.29 |
| 52-Week Range | $4.35 to $6.84 |
| RSI (14 Days) | 30.4 |
| Average Volume (20 Days) | 2.30M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.75x current liabilities, and total debt is 0.52x shareholder equity.
| Current Ratio | 1.75x |
|---|---|
| Quick Ratio | 0.96x |
| Debt / Equity | 0.52x |
| Debt / EBITDA | 2.10x |
| Debt / FCF | 14.25x |
| Interest Coverage | 2.43x |
Returns and Efficiency
Return on invested capital is 6.30% over the last 12 months, against a 5-year average of 11.70%.
| Return on Equity (ROE) | 4.99% |
|---|---|
| Return on Assets (ROA) | 2.33% |
| Return on Invested Capital (ROIC) | 6.30% |
| Return on Capital Employed (ROCE) | 8.43% |
| ROE (5Y Average) | 15.78% |
| ROA (5Y Average) | 7.28% |
| ROIC (5Y Average) | 11.70% |
| Asset Turnover | 0.61x |
| Inventory Turnover | 2.76x |
| Receivables Turnover | 4.92x |
| Cash Conversion Cycle | 132 days |
Taxes
Income tax took 33.58% of pretax income over the last 12 months.
| Income Tax (TTM) | $181.00M |
|---|---|
| Effective Tax Rate | 33.58% |
Scores
ICL has an Altman Z-Score of 2.11, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.11 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $7.77B over the last 12 months is up 10.15% from the 12 months before.
| Revenue | $7.77B |
|---|---|
| Revenue Growth (YoY) | +10.15% |
| Gross Profit | $2.39B |
| Operating Income | $831.00M |
| Pretax Income | $539.00M |
| Net Income | $310.00M |
| EBITDA | $1.55B |
| EBIT | $899.00M |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 46.84% of the $13.28B in total assets.
| Cash and Equivalents | $494.00M |
|---|---|
| Total Debt | $3.26B |
| Net Debt | $2.77B |
| Net Debt Per Share | $2.15 |
| Working Capital | $1.96B |
| Shareholder Equity | $6.22B |
| Book Value Per Share | $4.82 |
| Tangible Book Value | $5.26B |
| Tangible Book Per Share | $4.08 |
| Total Assets | $13.28B |
| Total Liabilities | $6.75B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $797.84M of capital spending, operating cash flow left $228.95M of free cash flow.
| Operating Cash Flow | $1.03B |
|---|---|
| Capital Expenditures | $797.84M |
| Free Cash Flow | $228.95M |
| FCF Per Share | $0.18 |
| Depreciation and Amortization | $653.00M |
| Dividends Paid | $272.18M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 10.70%, against a 5-year average of 17.76%.
| Gross Margin | 30.71% |
|---|---|
| Operating Margin | 10.70% |
| Pretax Margin | 6.94% |
| Net Margin | 3.99% |
| EBITDA Margin | 19.98% |
| EBIT Margin | 11.57% |
| FCF Margin | 2.95% |
| Gross Margin (5Y Average) | 37.35% |
| Operating Margin (5Y Average) | 17.76% |
| Net Margin (5Y Average) | 10.10% |
Growth
Revenue fell 10.61% a year over 3 years, and EPS 41.41% a year.
| Revenue Growth (3Y CAGR) | -10.61% |
|---|---|
| Revenue Growth (5Y CAGR) | +7.24% |
| EPS Growth (3Y CAGR) | -41.41% |
| EPS Growth (5Y CAGR) | +11.99% |
| FCF Growth (3Y CAGR) | -53.32% |
| FCF Growth (5Y CAGR) | -6.09% |
| Operating Income Growth (3Y CAGR) | -41.53% |
| Book Value Per Share Growth (2Y CAGR) | +1.81% |
| Tangible Book Per Share Growth (2Y CAGR) | +1.32% |
Dividends and Yields
ICL pays out 85.56% of earnings as dividends.
| Dividend Per Share (Annual) | $0.23 |
|---|---|
| Dividend Yield | 5.35% |
| Dividend Growth (3Y CAGR) | -47.47% |
| Dividend Growth (5Y CAGR) | +7.32% |
| Payout Ratio | 85.56% |
| FCF Payout Ratio | 118.88% |
| FCF Yield | 4.09% |
| Shareholder Yield | 4.86% |
Peer Position
Against 12 similar companies, ICL has the 8th highest P/S and the 3rd highest dividend yield.
P/S RatioPeer median 1.1x
ROICPeer median 4.89%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +5.30%
Dividend YieldPeer median 1.62%
| P/S Ratio | 0.7x vs 1.1x median |
|---|---|
| ROIC | 6.30% vs 4.89% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +10.15% vs +5.30% median |
| Dividend Yield | 5.35% vs 1.62% median |
Analyst Forecast
Consensus estimates put revenue growth at 6.91% and EPS growth at 9.33% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +6.91% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +9.33% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About ICL
What is ICL's market cap?
ICL Israel Chemicals has a market cap of $6.03B. Its enterprise value, which adds debt and subtracts cash, is $8.80B.
How many shares of ICL are outstanding?
ICL Israel Chemicals has 1.29B shares outstanding. The count is down 0.05% from a year earlier.
Does ICL pay a dividend?
Yes. ICL Israel Chemicals pays $0.23 a share a year, a dividend yield of 5.35%.
How much debt does ICL have?
ICL Israel Chemicals has $3.26B of total debt and $494.00M of cash and equivalents, a net debt position of $2.77B.
ICL pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors